The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Amphiphysin autoimmunity: Paraneoplastic accompaniments
Abstract
Amphiphysin‐IgG was identified in 71 patients among 120,000 evaluated serologically for paraneoplastic autoantibodies. Clinical information was available for 63 patients. Cancer was detected in 50 (mostly limited), proven histologically in 46, and was imaged intrathoracically in 4 patients (lung, small–cell [27] and non–small cell [1]), breast [16] and melanoma [2]). Neurological accompaniments included (decreasing frequency): neuropathy, encephalopathy, myelopathy, stiff‐man phenomena, and cerebellar syndrome. In a case examined neuropathologically, parenchymal T‐lymphocyte infiltration (predominantly CD8+) was prominent in lower brainstem, spinal cord, and dorsal root ganglion. Coexisting paraneoplastic autoantibodies, identified in 74% of patients, predicted a common neoplasm and indicated other neuronal autoantigen targets that plausibly explained several neurological manifestations; for example, P/Q‐type Ca 2+‐channel antibody with Lambert–Eaton syndrome (n = 5), anti‐neuronal nuclear antibody type 1 with sensory neuronopathy (n = 7), K+‐channel antibody with limbic encephalitis (n = 1) or neuromyotonia (n = 1), and collapsin response‐mediator protein‐5‐IgG with optic neuritis (n = 3). Patients with isolated amphiphysin‐IgG (n = 19) were more likely to be women (with breast cancer, p < 0.05) and to have myelopathy or stiff‐man phenomena (p < 0.01). Overall, a minority of women (39%) and men (12%) had stiff‐man phenomena. Only 10% of women (some with lung carcinoma) and 4% of men fulfilled diagnostic criteria for stiff‐man syndrome. Ann Neurol 2005;58:96–107
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dalmau, J., Graus, F., Rosenblum, M. K., & Posner, J. B. (1992) · MEDICINE · doi:10.1097/00005792-199203000-00001 · Cited by 819
Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes
Lennon, V. A., Kryzer, T. J., Griesmann, G. E., O'Suilleabhain, P. E., Windebank, A. J., Woppmann, A., Miljanich, G. P., & Lambert, E. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506013322203 · Cited by 603
Self-citationLucchinetti, C. F., Kimmel, D. W., & Lennon, V. A. (1998) · Neurology · doi:10.1212/wnl.50.3.652 · Cited by 499
Self-citationCytotoxic T lymphocytes in autoimmune and degenerative CNS diseases
Neumann, H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02154-9 · Cited by 480
Localization of 70-kDa stress protein induction in gerbil brain after ischemia
Vass, K., Welch, W. J., & Nowak, T. S. (1988) · Acta Neuropathologica · doi:10.1007/bf00687422 · Cited by 462
Moersch, F. P., & Woltman, H. W. (1956) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(26)01892-6 · Cited by 452
Tumor-specific killer cells in paraneoplastic cerebellar degeneration
Albert, M. L., Darnell, J. C., Bender, A., Francisco, L. M., Bhardwaj, N., & Darnell, R. B. (1998) · Nature Medicine · doi:10.1038/3315 · Cited by 449
Potassium channel antibodies in two patients with reversible limbic encephalitis
Buckley, C., Oger, J., Clover, L., Tüzün, E., Carpenter, K., Jackson, M., & Vincent, A. (2001) · Annals of Neurology · doi:10.1002/ana.1097 · Cited by 444
De Camilli, P., Thomas, A., Cofiell, R., Folli, F., Lichte, B., Piccolo, G., Meinck, H. M., Austoni, M., Fassetta, G., & Bottazzo, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2219 · Cited by 338
Anti‐neuronal nuclear autoantibody type 2: Paraneoplastic accompaniments
Pittock, S. J., Lucchinetti, C. F., & Lennon, V. A. (2003) · Annals of Neurology · doi:10.1002/ana.10518 · Cited by 331
Self-citation
Cited by
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Saiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., & Graus, F. (2008) · Brain · doi:10.1093/brain/awn183 · Cited by 623
Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
Lancaster, E., & Dalmau, J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.99 · Cited by 512
Leypoldt, F., Armangue, T., & Dalmau, J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12553 · Cited by 416
Antibodies and neuronal autoimmune disorders of the CNS
Graus, F., Saiz, A., & Dalmau, J. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5431-9 · Cited by 392
PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY
Hutchinson, M., Waters, P., McHugh, J., Gorman, G., O’Riordan, S., Connolly, S., Hager, H., Yu, P., Becker, C. M., & Vincent, A. (2008) · Neurology · doi:10.1212/01.wnl.0000327606.50322.f0 · Cited by 362
Autoimmune Epilepsy: Clinical Characteristics and Response to Immunotherapy
Quek, A. M. L. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2985 · Cited by 359
Cervical Spondylotic Myelopathy
Tracy, J. A., & Bartleson, J. D. (2010) · The Neurologist · doi:10.1097/nrl.0b013e3181da3a29 · Cited by 321
Stiff-Man Syndrome and Variants: Clinical Course, Treatments, and Outcomes
McKeon, A. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.991 · Cited by 300
Clinical spectrum of voltage-gated potassium channel autoimmunity
Tan, K. M., Lennon, V. A., Klein, C. J., Boeve, B. F., & Pittock, S. J. (2008) · Neurology · doi:10.1212/01.wnl.0000312275.04260.a0 · Cited by 281
Self-citationAn Approach to the Diagnosis of Acute Transverse Myelitis
Jacob, A., & Weinshenker, B. (2008) · Seminars in Neurology · doi:10.1055/s-2007-1019132 · Cited by 255
Metadata
- Authors
- Pittock, S. J., Lucchinetti, C. F., Parisi, J. E., Benarroch, E. E., Mokri, B., Stephan, C. L., Kim, K., Kilimann, M. W., & Lennon, V. A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2005-07
- Volume
- 58
- Issue
- 1
- Pages
- 96-107
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1983650864
- Cited by
- 369
- References
- 31
- FWCI
- 7.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.